AbCellera Biologics Inc. (ABCL) Net income 2019–2025
AbCellera Biologics Inc. (ABCL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$146.4MFY2025 · since FY2019: -$2.2M → -$146.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$146.4M | +10.1% |
| FY2024 | -$162.9M | -11.2% |
| FY2023 | -$146.4M | -192.4% |
| FY2022 | $158.5M | +3.3% |
| FY2021 | $153.5M | +29.1% |
| FY2020 | $118.9M | +5478.5% |
| FY2019 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABCL financial trends
ABCL RevenueABCL Net marginABCL Gross profitABCL Gross marginABCL Operating incomeABCL Operating marginABCL Operating cash flowABCL Free cash flowABCL Capital expendituresABCL Return on equityABCL Stock buybacksABCL Dividends paidABCL Total assetsABCL Total liabilitiesABCL Shareholders’ equityABCL overview →